Detalhe da pesquisa
1.
Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade.
Cancer Res Commun
; 3(8): 1564-1579, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37593752